Cargando…

Response to a trial on reversal of Death by Neurologic Criteria

Detalles Bibliográficos
Autores principales:	Lewis, Ariane, Caplan, Arthur
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5118884/ https://www.ncbi.nlm.nih.gov/pubmed/27871305 http://dx.doi.org/10.1186/s13054-016-1561-5

Ejemplares similares

A response to “Response to a Trial on Reversal of Death by Neurologic Criteria”
por: Pastor, Ira S.
Publicado: (2017)

Quality improvement in the determination of death by neurologic criteria around the world
por: Lewis, Ariane, et al.
Publicado: (2023)

Determination of Brain Death/Death by Neurologic Criteria in Countries in Asia and the Pacific
por: Lewis, Ariane, et al.
Publicado: (2020)

Revise the Uniform Determination of Death Act to Align the Law With Practice Through Neurorespiratory Criteria
por: Omelianchuk, Adam, et al.
Publicado: (2022)

Ancillary Tests for Death by Neurologic Criteria in Children
por: Mayne, Elizabeth, et al.
Publicado: (2020)

Practice Variability in Determination of Death by Neurologic Criteria for Adult Patients
por: Junn, Alexandra, et al.
Publicado: (2019)

Death determination by neurologic criteria—what do families understand?
por: Sarti, Aimee J., et al.
Publicado: (2023)

Correction: Death determination by neurologic criteria—what do families understand?
por: Sarti, Aimee J., et al.
Publicado: (2023)

Infratentorial brain injury and death by neurologic criteria in Canada: a narrative review
por: Shemie, Sam D., et al.
Publicado: (2023)

Comments on "Unilateral Reversible Posterior Leukoencephalopathy Syndrome after Coiling of an Aneurysm"
por: Caplan, Louis R
Publicado: (2014)

Potential pharmacological confounders in the setting of death determined by neurologic criteria: a narrative review
por: Kanji, Salmaan, et al.
Publicado: (2023)

Opinions on the Legitimacy of Death Declaration by Neurological Criteria from the Perspective of 3 Abrahamic Faiths
por: Miller, Andrew C
Publicado: (2019)

The Maze of Vasodilator Response Criteria
por: Douwes, J. Menno, et al.
Publicado: (2010)

Diagnostic accuracy of ancillary tests for death by neurologic criteria: a systematic review and meta-analysis
por: Neves Briard, Joel, et al.
Publicado: (2023)

Relationship of different platelet response criteria and patient outcomes in a romiplostim myelodysplastic syndromes trial
por: Platzbecker, U, et al.
Publicado: (2014)

Posterior reversible encephalopathy syndrome (PRES) as a neurological association in severe Covid-19
por: Kishfy, Louis, et al.
Publicado: (2020)

Confirmatory digital subtraction angiography after clinical brain death/death by neurological criteria: impact on number of donors and organ transplants
por: Hansen, Karen Irgens Tanderup, et al.
Publicado: (2023)

Requests for somatic support after neurologic death determination: Canadian physician experiences
por: van Beinum, Amanda, et al.
Publicado: (2020)

Prospective evaluation of lymphoma response to immunomodulatory therapy criteria in GATA trial from the LYSA group
por: Al Tabaa, Yassine, et al.
Publicado: (2023)

Bench-to-bedside review: When is dead really dead – on the legitimacy of using neurologic criteria to determine death
por: Whetstine, Leslie M
Publicado: (2007)

Plagiarism: Challenges and Criteria
por: Wiwanitkit, Viroj
Publicado: (2017)

Excess neurological death in New York City after the emergence of COVID-19
por: de Havenon, Adam, et al.
Publicado: (2020)

Updated Diagnostic Criteria for Paraneoplastic Neurologic Syndromes
por: Graus, Francesc, et al.
Publicado: (2021)

The practical role of the respiratory therapist in the standard apnea test procedure for declaration of death via neurologic criteria in adults
por: Jarquin-Valdivia, Adrian A., et al.
Publicado: (2022)

Response to “Critical Analysis of Apixaban Dose Adjustment Criteria”
por: Mandt, Stephen R., et al.
Publicado: (2022)

Ancillary radionuclide perfusion studies in the determination of death by neurologic criteria: methods, interpretation, and lexicon—a user guide for the clinician
por: Zuckier, Lionel S., et al.
Publicado: (2023)

The criteria of eligibility to the extracorporeal treatment
por: Zangrillo, A
Publicado: (2012)

Proposed criteria for schizophrenia remission
por: AlAqeel, Bandar
Publicado: (2014)

A brain-based definition of death and criteria for its determination after arrest of circulation or neurologic function in Canada: a 2023 clinical practice guideline
por: Shemie, Sam D., et al.
Publicado: (2023)

Modifications to predefined rapid response team calling criteria: prevalence, characteristics and associated outcomes
por: Chen, Qin Ting, et al.
Publicado: (2023)

A Framework for Revisiting Brain Death: Evaluating Awareness and Attitudes Toward the Neuroscientific and Ethical Debate Around the American Academy of Neurology Brain Death Criteria
por: Chatterjee, Krishanu, et al.
Publicado: (2021)

Sudden and early death among medical professionals: How to reverse this trend?
por: Pandey, Suresh K, et al.
Publicado: (2023)

Response: Proposed Diagnostic Criteria for Definite Isolated Otolith Dysfunction
por: Suh, Myung-Whan, et al.
Publicado: (2021)

On the authorship criteria
por: Rakhshan, Vahid
Publicado: (2014)

Consent for determination of death by neurologic criteria in Canada: an analysis of legal and ethical authorities, and consensus-based working group recommendations
por: Pope, Thaddeus M., et al.
Publicado: (2023)

COVID vaccine efficacy against the B.1.351 (“South African”) variant—The urgent need to lay the groundwork for possible future challenge studies
por: Eyal, Nir, et al.
Publicado: (2021)

Response to ‘Lack of reversibility for NOACs’
por: Kaba, Riyaz A, et al.
Publicado: (2014)

Leptomeningeal disease and neurologic death after surgical resection and radiosurgery for brain metastases: A multi-institutional analysis
por: Prabhu, Roshan S., et al.
Publicado: (2021)

Chimeric Antigen Receptor T-cell Therapy: Imaging Response Criteria and Relation to Progression-free and Overall Survival
por: Winkelmann, Michael, et al.
Publicado: (2022)

Should patient enrollment criteria for anti‐VEGF phase III trials be reconsidered
por: Hanhart, Joel, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ioppnqe92ejm95pvgaf3633d30